| Gregory Paul Stiener, MD | |
|
1011 Veterans Memorial Pkwy, Riverside, RI 02915-5061 | |
| (401) 432-1000 | |
| Not Available |
| Full Name | Gregory Paul Stiener |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1011 Veterans Memorial Pkwy, Riverside, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033270459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | MD09170 (Rhode Island) | Primary |
| Entity Name | Emma Pendleton Bradley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578768867 PECOS PAC ID: 3870527526 Enrollment ID: O20050921001082 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
"Today marks an historic milestone in the search for an AIDS vaccine; we now have evidence that it is possible to reduce the risk of HIV infection with a vaccine," said AVAC executive director Mitchell Warren, reacting to the results of the first AIDS vaccine trial to ever show efficacy at preventing HIV. "It will take time and resources to fully analyze, understand and validate the data, but there is little doubt that this finding will energize and redirect the AIDS vaccine field as all of us begin the hard work to translate this landmark result into true public health benefit."
Eurofins MWG Operon, an expert in next generation sequencing and Certified Service Provider for Roche NimbleGen sequence capture, together with Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce that they have developed a complete human exome array, based on Roche NimbleGen sequence capture technology.
Persons with Alzheimer's disease have approximately 30% higher risk of head injuries, and 50% higher risk of traumatic brain injuries than persons without Alzheimer's disease, a recent study from University of Eastern Finland shows.
With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.
› Verified 6 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548506793 PECOS PAC ID: 2567455082 Enrollment ID: O20130528000089 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
"Today marks an historic milestone in the search for an AIDS vaccine; we now have evidence that it is possible to reduce the risk of HIV infection with a vaccine," said AVAC executive director Mitchell Warren, reacting to the results of the first AIDS vaccine trial to ever show efficacy at preventing HIV. "It will take time and resources to fully analyze, understand and validate the data, but there is little doubt that this finding will energize and redirect the AIDS vaccine field as all of us begin the hard work to translate this landmark result into true public health benefit."
Eurofins MWG Operon, an expert in next generation sequencing and Certified Service Provider for Roche NimbleGen sequence capture, together with Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce that they have developed a complete human exome array, based on Roche NimbleGen sequence capture technology.
Persons with Alzheimer's disease have approximately 30% higher risk of head injuries, and 50% higher risk of traumatic brain injuries than persons without Alzheimer's disease, a recent study from University of Eastern Finland shows.
With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Paul Stiener, MD 117 Ellenfield St Ste 101, Providence, RI 02905-4541 Ph: (401) 444-6779 | Gregory Paul Stiener, MD 1011 Veterans Memorial Pkwy, Riverside, RI 02915-5061 Ph: (401) 432-1000 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
"Today marks an historic milestone in the search for an AIDS vaccine; we now have evidence that it is possible to reduce the risk of HIV infection with a vaccine," said AVAC executive director Mitchell Warren, reacting to the results of the first AIDS vaccine trial to ever show efficacy at preventing HIV. "It will take time and resources to fully analyze, understand and validate the data, but there is little doubt that this finding will energize and redirect the AIDS vaccine field as all of us begin the hard work to translate this landmark result into true public health benefit."
Eurofins MWG Operon, an expert in next generation sequencing and Certified Service Provider for Roche NimbleGen sequence capture, together with Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce that they have developed a complete human exome array, based on Roche NimbleGen sequence capture technology.
Persons with Alzheimer's disease have approximately 30% higher risk of head injuries, and 50% higher risk of traumatic brain injuries than persons without Alzheimer's disease, a recent study from University of Eastern Finland shows.
With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.
› Verified 6 days ago
Justyna Piasecka, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1011 Veterans Memorial Pkwy, Riverside, RI 02915 Phone: 401-432-1000 Fax: 401-432-1000 | |
Dr. Ornella Judith Potter, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1011 Veterans Memorial Pkwy, Riverside, RI 02915 Phone: 401-432-1000 Fax: 401-432-1500 | |
Tanuja P Gandhi, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1011 Veterans Memorial Pkwy, Riverside, RI 02915 Phone: 401-432-1000 Fax: 401-432-1500 | |
Dr. Achina P Stein, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 250 Wampanoag Trl Ste 305, Riverside, RI 02915 Phone: 401-270-4541 Fax: 401-270-4081 | |
Noha Sadek, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1011 Veterans Memorial Pkwy, Riverside, RI 02915 Phone: 401-432-1000 | |
Alaa Elnajjar, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1011 Veterans Memorial Pkwy, Riverside, RI 02915 Phone: 401-432-1137 Fax: 401-432-1509 |